Ubs Group Ag Dr Reddys Laboratories LTD Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ubs Group Ag holds 17,217 shares of RDY stock, worth $240,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,217
Previous 37,028
53.5%
Holding current value
$240,521
Previous $2.82 Million
51.54%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding RDY
# of Institutions
254Shares Held
37.6MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$160 Million0.35% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa2.47MShares$34.5 Million0.02% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31.3 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$27.9 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.2 Million0.25% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.32B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...